Research progress on correlation between coronavirus disease 2019 and obstructive sleep apnea hypopnea syndrome

YAN Jiayu; GU Ning

doi:10.7619/jcmp.20232981

Journal of Clinical Medicine in Practice > 2024 > 28(8): 142-148. > DOI: 10.7619/jcmp.20232981

YAN Jiayu, GU Ning. Research progress on correlation between coronavirus disease 2019 and obstructive sleep apnea hypopnea syndrome[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 142-148. DOI: 10.7619/jcmp.20232981

Citation:

PDF (999 KB)

Research progress on correlation between coronavirus disease 2019 and obstructive sleep apnea hypopnea syndrome

YAN Jiayu¹,
GU Ning^2, ,

1.
Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210029
2.
Department of Cardiology, Nanjing Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210022

More Information

Received Date: September 18, 2023
Revised Date: November 28, 2023
Available Online: May 05, 2024

Graphical Abstract

Abstract

Abstract

Since December 2019, the rapid spread of coronavirus disease 2019 (COVID-19) poses a serious threat to global public health security. Obstructive sleep apnea hypopnea syndrome (OSAHS) is commonly occurred in patients with COVID-19, however, due to the lack of understanding of their comorbidities, the damage of OSAHS is often underestimated or even ignored. OSAHS has not been identified as an independent risk factor that increases the possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and aggravates the disease. In addition, the understanding of traditional Chinese medicine for the prevention and treatment of novel coronavirus pneumonia complicated with OSAHS at home and abroad is not profound, and related studies are also few. The purpose of this article is to improve clinicians' knowledge and understanding of COVID-19 combined with OSAHS, which may provide some guidance in dealing with this disease.

FullText(HTML)

References (49)

References

[1]	BENJAFIELD A V, AYAS N T, EASTWOOD R, et al. Estimation of the global prevalence and burden of obstructive sleeapnoea: a literature-based analysis[J]. Lancet Respir Med, 2019, 7(8): 687-698. doi: 10.1016/S2213-2600(19)30198-5
[2]	GOTTLIEB D J, PUNJABI N M. Diagnosis and management of obstructive sleeapnea: a review[J]. JAMA, 2020, 323(14): 1389-1400. doi: 10.1001/jama.2020.3514
[3]	BHATRAJU K, GHASSEMIEH B J, NICHOLS M, et al. Covid-19 in critically ill patients in the Seattle region-case series[J]. N Engl Med, 2020, 382(21): 2012-2022. doi: 10.1056/NEJMoa2004500
[4]	ARENTZ M, YIM E, KLAFF L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state[J]. JAMA, 2020, 323(16): 1612-1614. doi: 10.1001/jama.2020.4326
[5]	STRAUSZ S, KIISKINEN T, BROBERG M, et al. Sleeapnoea is a risk factor for severe COVID-19[J]. BMOpen Respir Res, 2021, 8(1): e000845. doi: 10.1136/bmjresp-2020-000845
[6]	MAAS M B, KIM M, MALKANI R G, et al. Obstructive sleeapnea and risk of COVID-19 infection, hospitalization and respiratory failure[J]. Schlaf Atmung, 2021, 25(2): 1155-1157.
[7]	HARIYANTO T I, KURNIAWAN A. Obstructive sleeapnea (OSA) and outcomes from coronavirus disease 2019(COVID-19) pneumonia: a systematic review and meta-analysis[J]. SleeMed, 2021, 82: 47-53.
[8]	VONCKEN S F J, FERON T M H, LAVEN S A S, et al. Impact of obstructive sleeapnea on clinical outcomes in patients hospitalized with COVID-19[J]. Schlaf Atmung, 2022, 26(3): 1399-1407.
[9]	GAO X, WEI T, WANG H J, et al. Causal associations between obstructive sleeapnea and COVID-19: a bidirectional Mendelian randomization study[J]. SleeMed, 2023, 101: 28-35.
[10]	PEKER Y, CELIK Y, ARBATLI S, et al. Effect of high-risk obstructive sleeapnea on clinical outcomes in adults with coronavirus disease 2019: a multicenter, prospective, observational clinical trial[J]. Ann Am Thorac Soc, 2021, 18(9): 1548-1559. doi: 10.1513/AnnalsATS.202011-1409OC
[11]	NAJAFI A, SADEGHNIIAT-HAGHIGHI K, AKBARPOUR S, et al. The effect of apnea management on novel coronavirus infection: a study on patients with obstructive sleeapnea[J]. SleeHealth, 2021, 7(1): 14-18.
[12]	HUANG C L, HUANG L X, WANG Y M, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study[J]. Lancet, 2023, 401(10393): e21-e33. doi: 10.1016/S0140-6736(23)00810-3
[13]	JENNINGS G, MONAGHAN A, XUE F, et al. A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome[J]. Clin Med, 2021, 10(24): 5913.
[14]	AL-ALY Z, XIE Y, BOWE B. High-dimensional characterization of post-acute sequelae of COVID-19[J]. Nature, 2021, 594(7862): 259-264. doi: 10.1038/s41586-021-03553-9
[15]	LIN W C, WU M C, WANG Y H, et al. The prevalence of obstructive sleeapnea syndrome after COVID-19 infection[J]. Med Virol, 2024, 96(1): e29392. doi: 10.1002/jmv.29392
[16]	ZHOU F, YU T, DU R H, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. Lancet, 2020, 395(10229): 1054-1062. doi: 10.1016/S0140-6736(20)30566-3
[17]	TUFIK S, GOZAL D, ISHIKURA I A, et al. Does obstructive sleeapnea lead to increased risk of COVID-19 infection and severity[J]. Clin SleeMed, 2020, 16(8): 1425-1426.
[18]	RICHARDSON S, HIRSCH S, NARASIMHAN M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area[J]. JAMA, 2020, 323(20): 2052-2059.
[19]	MEIRA E CRUZ M, MIYAZAWA M, GOZAL D. Putative contributions of circadian clock and sleein the context of SARS-CoV-2 infection[J]. Eur Respir J, 2020, 55(6): 2001023.
[20]	NIU S M, TIAN S J, LOU J, et al. Clinical characteristics of older patients infected with COVID-19: a descriptive study[J]. Arch Gerontol Geriatr, 2020, 89: 104058.
[21]	WU C M, CHEN X Y, CAI Y P, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China[J]. JAMA Intern Med, 2020, 180(7): 934-943.
[22]	MALHOTRA A, HUANG Y Q, FOGEL R, et al. Aging influences on pharyngeal anatomy and physiology: the predisposition to pharyngeal collapse[J]. Am Med, 2006, 119(1): 72. e9-72. e14.
[23]	苏小凤, 刘霖, 仲琳, 等. 中国阻塞性睡眠呼吸暂停综合征患病率的Meta分析[J]. 中国循证医学杂志, 2021, 21(10): 1187-1194. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ202110012.htm
[24]	KAR A, SAXENA K, GOYAL A, et al. Assessment of obstructive sleeapnea in association with severity of COVID-19: a prospective observational study[J]. SleeVigil, 2021, 5(1): 111-118.
[25]	SIMONNET A, CHETBOUN M, POISSY J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2(SARS-CoV-2) requiring invasive mechanical ventilation[J]. Obesity, 2020, 28(7): 1195-1199.
[26]	DIXON A E, PETERS U. The effect of obesity on lung function[J]. Expert Rev Respir Med, 2018, 12(9): 755-767.
[27]	FENG H Y, GAN C C R, LEIVA D, et al. COVID-19, sex, and gender in China: a scoping review[J]. Global Health, 2022, 18(1): 9.
[28]	FIDECICCHI T, FRUZZETTI F, LETE LASA L I, et al. COVID-19, gender and estroprogestins, what do we know?[J]. Eur Contracept Reprod Health Care, 2022, 27(1): 67-74.
[29]	DENG W, ZHOU F W, HOU W T, et al. The prevalence of depression, anxiety, and sleedisturbances in COVID-19 patients: a meta-analysis[J]. Ann N Y Acad Sci, 2021, 1486(1): 90-111.
[30]	BOESL F, AUDEBERT H, ENDRES M, et al. A neurological outpatient clinic for patients with post-COVID-19 syndrome-A report on the clinical presentations of the first 100 patients[J]. Front Neurol, 2021, 12: 738405.
[31]	DAVIS C J, DUNBRASKY D, OONK M, et al. The neuron-specific interleukin-1 receptor accessory protein is required for homeostatic sleeand sleeresponses to influenza viral challenge in mice[J]. Brain Behav Immun, 2015, 47: 35-43.
[32]	SEMYACHKINA-GLUSHKOVSKAYA O, MAMEDOVA A, VINNIK V, et al. Brain mechanisms of COVID-19-sleedisorders[J]. Int Mol Sci, 2021, 22(13): 6917.
[33]	YANG A G, LI B C, ZHU C X, et al. Prevalence of and risk factors associated with sleedisturbances among HPCD exposed to COVID-19 in China[J]. SleeMedicine, 2021, 80: 16-22.
[34]	PATT B T, JARJOURA D, HADDAD D N, et al. Endothelial dysfunction in the microcirculation of patients with obstructive sleeapnea[J]. Am Respir Crit Care Med, 2010, 182(12): 1540-1545.
[35]	HELMS J, KREMER S, MERDJI H, et al. Neurologic features in severe SARS-CoV-2 infection[J]. N Engl Med, 2020, 382(23): 2268-2270.
[36]	WU G, XU G, CHEN D W, et al. Hypoxia exacerbates inflammatory acute lung injury via the toll-like receptor 4 signaling pathway[J]. Front Immunol, 2018, 9: 1667.
[37]	JIN Z N, WEI Y X. Meta-analysis of effects of obstructive sleeapnea on the renin-angiotensin-aldosterone system[J]. Geriatr Cardiol, 2016, 13(4): 333-343.
[38]	BARCELÓ A, ELORZA M A, BARBÉ F, et al. Angiotensin converting enzyme in patients with sleeapnoea syndrome: plasma activity and gene polymorphisms[J]. Eur Respir J, 2001, 17(4): 728-732.
[39]	许李娜, 张念志. 532例阻塞性睡眠呼吸暂停综合征患者中医证候学研究[J]. 中国中医急症, 2016, 25(1): 34-36. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJZ201601012.htm
[40]	罗辉, 王琦. 中医体质与新型冠状病毒感染相关性研究的系统评价和Meta分析[J]. 中医杂志, 2023, 64(11): 1117-1123. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202311008.htm
[41]	傅慧婷, 余小萍. 肺通调水道功能与气道黏液高分泌[J]. 新中医, 2013, 45(3): 5-7. https://www.cnki.com.cn/Article/CJFDTOTAL-REND201303002.htm
[42]	赵彦青, 宫剑鸣, 李亚翔, 等. 王松龄治疗阻塞性睡眠呼吸暂停低通气综合征的思路和经验[J]. 辽宁中医杂志, 2016, 43(9): 1835-1836. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201609011.htm
[43]	SHANG F, WANG SC, GONGOL B, et al. Obstructive SleeApnea-induced Endothelial Dysfunction Is Mediated by miR-210[J]. Am Respir Crit Care Med. 2023, 207(3): 323-335.
[44]	周澧, 秦川. 2019新型冠状病毒肺炎凝血异常机制与中医血瘀证候[J]. 中国比较医学杂志, 2022, 32(1): 89-96. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGDX202201013.htm
[45]	BAKER G, SOVANI M. Case for continuing community NIV and CPAduring the COVID-19 epidemic[J]. Thorax, 2020, 75(5): 368.
[46]	NING Y, ZHANG T S, WEN W W, et al. Effects of continuous positive airway pressure on cardiovascular biomarkers in patients with obstructive sleeapnea: a meta-analysis of randomized controlled trials[J]. Schlaf Atmung, 2019, 23(1): 77-86.
[47]	DRUMMOND M. Sleelabs, lung function tests and COVID-19 pandemic-Only emergencies allowed![J]. Pulmonology, 2020, 26(4): 244-245.
[48]	袁蓉, 信琪琪, 唐仕欢, 等. 中医整体观指导下的COVID-19治疗: 同时着眼于病毒和宿主的疗法[J]. 中国中药杂志, 2020, 45(7): 1521-1525. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202007008.htm
[49]	陈丹, 倪明珠, 杨建强, 等. 新型冠状病毒肺炎患者和援鄂医护人员睡眠状况调查及睡眠障碍干预研究[J]. 世界睡眠医学杂志, 2020, 7(5): 753-757. https://www.cnki.com.cn/Article/CJFDTOTAL-SMZZ202005003.htm

Cited By

Get Citation

PDF

XML

Article views (117) PDF downloads (13)

Turn off MathJax

Article Contents

Abstract

References

Research progress on correlation between coronavirus disease 2019 and obstructive sleep apnea hypopnea syndrome

Abstract

References

Catalog

Export File

Citation

Format

Content